AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

PROK vs SCTX: stock comparison and AI forecast

Prokidney Corp. (PROK) and Scribe Therapeutics, Inc. (SCTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

PROK Prokidney Corp.

Price
$1.06 -43.4% · 6M
Market Cap
$322M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

SCTX Scribe Therapeutics, Inc.

Market Cap
$293M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

PROK · SCTX

Key facts

  • PROK and SCTX have similar market capitalizations ($322M and $293M).
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricPROKSCTX
Market Cap$322M$293M
Revenue/Share$0.00–
FCF/Share$-0.53–

Profitability & Margins

MetricPROKSCTX
Tax Rate0.6%–

Financial Health

MetricPROKSCTX
Current Ratio8.36x0.57x
Interest Coverage-2995.5x-10.7x
Working Capital$167M-$34M

Cash Flow

MetricPROKSCTX
Operating Cash Flow-$141M–
Free Cash Flow-$160M–
Capital Spending-$19M–
FCF/Sales-19527.4%–
CapEx/Sales2269.8%–

Operational Efficiency

MetricPROKSCTX
Fixed Assets Turnover0.0x–

Income Statement

MetricPROKSCTX
Total Revenue$820K–
Operating Income-$177M–
Net Income-$98M–
R&D Expense$131M–

Dividend & Shareholder Information

MetricPROKSCTX
Shares Outstanding302M19M
FAQ

PROK vs SCTX: stock comparison and AI forecast

Which is bigger, PROK or SCTX?

PROK and SCTX have similar market capitalizations ($322M and $293M).

Which one does Intratio's AI model rank higher, PROK or SCTX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.